Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 8504715Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2025
Linked Award Amount
$4.1M
Full award amounts, FY2025
Award Records
2
Records listing this PI
Award-Linked Rank
#2,004
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Pingsheng Wu as a PI. Multi-PI records show the full award amount for context.
- 1R01AI187287-01A1R01The uptake and real-world effectiveness of emerging respiratory syncytial virus maternal vaccines and monoclonal antibodies on short- and long-term respiratory morbidities$3.3Maward amount
- 5R01HL173480-02R01Establishing critical time windows of infant RSV infection in the causal relationship of RSV and childhood asthma$767.6Kaward amount
Award organization
Organizations that administered FY2025 awards listing Pingsheng Wu as a PI.
FY2025 award administered by Vanderbilt University Medical Center (TN).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardVanderbilt University Medical Center
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #8869
- 2025$2M Cumulative Funding
- 2025$5M Cumulative Funding
- 2025Entered Top 25% NationallyRanked #2004
- 2025R01 Grant Holder
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Pingsheng Wu.